Skip to main contentSkip to navigation
Sirius Investors
Aida Pharmaceuticals, Inc.

Aida Pharmaceuticals, Inc.

AIDA
OTC•Healthcare

Market Capitalization & Enterprise Value

Research-grade valuation history for AIDA. Track market capitalization versus enterprise value to see the impact of net debt and share changes. Use the interactive chart to explore different horizons; the table updates accordingly to support auditability and export.

Quick links:Overview•Financial Metrics•Technicals•Returns•Financials•Performance

Market Cap & Enterprise Value

Comparison of market capitalization and enterprise value over time

Market Cap

Market Capitalization = Stock Price × Number of Shares Outstanding. Represents the total value of a company's equity.
30.51M
+171.91% over period
CAGR: +39.58%
Compound Annual Growth Rate - The mean annual growth rate over time, accounting for compounding effects.

Enterprise Value

Enterprise Value = Market Cap + Total Debt - Cash and Cash Equivalents. Represents the total value of a company including its debt.
55.48M
+394.44% over period
CAGR: +70.36%
Compound Annual Growth Rate - The mean annual growth rate over time, accounting for compounding effects.

Market Cap History

Investor Valuation Insights

As of Sep 30, 2008

EV/EBITDA

Fair Range

13.59x

This is a common valuation range; compare to peers and growth outlook before concluding.

EV vs Market Cap Spread

24.97M

EV is +81.8% vs equity value

Capital Structure Signal

Net Debt Profile

EV premium trend: +81.8 pp vs earliest data

Additional Multiples

EV/Sales: 3.84x

Net Debt/EBITDA: 9.80x

Share count change in dataset: +15.50%

Interpretation guide: EV/EBITDA compares total firm value (debt + equity - cash) to operating earnings. Lower is usually cheaper, but always benchmark against peers, growth rate, margins, and cyclicality.

Market Cap & Enterprise Value Data

Free users can view the latest 3 records. Upgrade to see full history.

Upgrade
DateMarket CapEnterprise ValueStock PriceShares
Dec 31, 200730.51M55.48M$1.1327.00M
Dec 31, 200646.72M70.15M$1.8025.95M
Dec 31, 200543.44M65.48M$1.8523.48M
Dec 31, 2004
————

Enterprise Value Analysis

Price Change (Dec 2006 to Dec 2007)

The stock price has decreased from Dec 2006 to Dec 2007.
-37.22%

Recent Volatility

The stock price has been relatively volatile over the last 4 periods, indicating a higher risk profile.
1.45

Risk-Adjusted Return

The stock offers a reasonable return for its level of risk.
0.57

Market Cap Change (Dec 2006 to Dec 2007)

The company's market capitalization has decreased from Dec 2006 to Dec 2007.
-34.69%

Enterprise Value Change (Dec 2006 to Dec 2007)

The company's enterprise value has decreased from Dec 2006 to Dec 2007, suggesting a decline in the company's total economic value.
-20.92%

Market Cap vs. Enterprise Value

A higher enterprise value growth rate compared to market cap growth could indicate that the company is investing heavily in growth initiatives or taking on more debt.
EV Growth > Market Cap Growth

Market Cap CAGR

The Compound Annual Growth Rate (CAGR) of market capitalization represents the mean annual growth rate over the entire available history (4 periods), accounting for compounding effects.
39.58%

Enterprise Value CAGR

The Compound Annual Growth Rate (CAGR) of enterprise value represents the mean annual growth rate over the entire available history (4 periods), accounting for compounding effects.
70.36%